Ligand validation:9FMI

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 9FMI designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9FMI_SAH_A_401	100%	57%	0.03	0.995	0.65	0.98	-	2	0	0	100%	1
9FMH_SAH_A_401	100%	50%	0.034	0.994	0.8	1.13	1	2	1	0	100%	1
8PB4_SAH_A_401	91%	48%	0.1	0.987	0.81	1.18	1	2	0	0	100%	1
8PB6_SAH_A_401	90%	42%	0.103	0.988	1.02	1.24	-	4	0	0	100%	1
8QXQ_SAH_A_401	87%	51%	0.109	0.982	0.84	1.04	1	2	0	0	100%	1
8PB3_SAH_A_401	86%	46%	0.096	0.963	0.93	1.14	2	2	1	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1
6I73_SAH_A_401	100%	49%	0.028	0.992	0.78	1.16	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.